Insulet Operating Margin 2011-2025 | PODD
Current and historical operating margin for Insulet (PODD) over the last 10 years. The current operating profit margin for Insulet as of September 30, 2025 is 13.01%.
| Insulet Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-09-30 | $2.52B | $0.44B | 17.33% |
| 2025-06-30 | $2.36B | $0.41B | 17.25% |
| 2025-03-31 | $2.20B | $0.34B | 15.50% |
| 2024-12-31 | $2.07B | $0.31B | 14.91% |
| 2024-09-30 | $1.99B | $0.31B | 15.42% |
| 2024-06-30 | $1.87B | $0.27B | 14.57% |
| 2024-03-31 | $1.78B | $0.25B | 13.97% |
| 2023-12-31 | $1.70B | $0.22B | 12.96% |
| 2023-09-30 | $1.56B | $0.14B | 8.86% |
| 2023-06-30 | $1.47B | $0.09B | 5.87% |
| 2023-03-31 | $1.37B | $0.03B | 2.05% |
| 2022-12-31 | $1.31B | $0.04B | 2.91% |
| 2022-09-30 | $1.24B | $0.06B | 5.15% |
| 2022-06-30 | $1.18B | $0.10B | 8.06% |
| 2022-03-31 | $1.14B | $0.15B | 12.96% |
| 2021-12-31 | $1.10B | $0.13B | 11.46% |
| 2021-09-30 | $1.04B | $0.07B | 6.65% |
| 2021-06-30 | $1.00B | $0.06B | 5.93% |
| 2021-03-31 | $0.96B | $0.06B | 6.37% |
| 2020-12-31 | $0.90B | $0.05B | 5.86% |
| 2020-09-30 | $0.87B | $0.08B | 9.00% |
| 2020-06-30 | $0.83B | $0.07B | 8.61% |
| 2020-03-31 | $0.78B | $0.05B | 6.57% |
| 2019-12-31 | $0.74B | $0.05B | 6.78% |
| 2019-09-30 | $0.69B | $0.05B | 6.92% |
| 2019-06-30 | $0.65B | $0.04B | 5.82% |
| 2019-03-31 | $0.60B | $0.03B | 5.67% |
| 2018-12-31 | $0.56B | $0.03B | 4.79% |
| 2018-09-30 | $0.53B | $0.01B | 1.89% |
| 2018-06-30 | $0.50B | $0.01B | 1.00% |
| 2018-03-31 | $0.49B | $0.00B | -0.41% |
| 2017-12-31 | $0.47B | $-0.01B | -1.51% |
| 2017-09-30 | $0.44B | $-0.01B | -2.28% |
| 2017-06-30 | $0.41B | $-0.01B | -2.43% |
| 2017-03-31 | $0.39B | $-0.01B | -2.06% |
| 2016-12-31 | $0.37B | $-0.01B | -3.00% |
| 2016-09-30 | $0.35B | $-0.02B | -5.76% |
| 2016-06-30 | $0.32B | $-0.04B | -11.46% |
| 2016-03-31 | $0.30B | $-0.05B | -16.84% |
| 2015-12-31 | $0.26B | $-0.05B | -18.56% |
| 2015-09-30 | $0.20B | $-0.04B | -17.95% |
| 2015-06-30 | $0.20B | $-0.02B | -11.56% |
| 2015-03-31 | $0.21B | $-0.01B | -6.67% |
| 2014-12-31 | $0.23B | $-0.01B | -3.90% |
| 2014-09-30 | $0.29B | $-0.01B | -3.51% |
| 2014-06-30 | $0.27B | $-0.02B | -8.86% |
| 2014-03-31 | $0.26B | $-0.03B | -9.65% |
| 2013-12-31 | $0.25B | $-0.03B | -11.74% |
| 2013-09-30 | $0.24B | $-0.04B | -14.83% |
| 2013-06-30 | $0.23B | $-0.03B | -11.30% |
| 2013-03-31 | $0.22B | $-0.03B | -14.03% |
| 2012-12-31 | $0.21B | $-0.04B | -16.98% |
| 2012-09-30 | $0.20B | $-0.04B | -20.40% |
| 2012-06-30 | $0.19B | $-0.04B | -22.51% |
| 2012-03-31 | $0.17B | $-0.05B | -27.33% |
| 2011-12-31 | $0.15B | $-0.04B | -28.29% |
| 2011-09-30 | $0.13B | $-0.04B | -31.58% |
| 2011-06-30 | $0.11B | $-0.04B | -35.40% |
| 2011-03-31 | $0.10B | $-0.04B | -33.65% |
| 2010-12-31 | $0.10B | $-0.04B | -40.21% |
| 2010-09-30 | $0.09B | $-0.04B | -46.07% |
| 2010-06-30 | $0.08B | $-0.05B | -55.42% |
| 2010-03-31 | $0.08B | $-0.05B | -69.33% |
| 2009-12-31 | $0.07B | $-0.06B | -87.88% |
| 2009-09-30 | $0.06B | $-0.07B | -125.86% |
| 2009-06-30 | $0.05B | $-0.08B | -163.27% |
| 2009-03-31 | $0.04B | $-0.09B | -209.76% |
| 2008-12-31 | $0.04B | $-0.09B | -247.22% |
| 2008-09-30 | $0.03B | $-0.08B | -278.57% |
| 2008-06-30 | $0.02B | $-0.07B | -331.82% |
| 2008-03-31 | $0.02B | $-0.06B | -350.00% |
| 2007-12-31 | $0.01B | $-0.05B | -415.38% |
| 2007-09-30 | $0.01B | $-0.05B | -427.27% |
| 2007-06-30 | $0.01B | $-0.04B | -525.00% |
| 2007-03-31 | $0.01B | $-0.04B | -650.00% |
| 2006-12-31 | $0.00B | $-0.04B | -875.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $23.696B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.002B | 25.82 |
| EssilorLuxottica (ESLOY) | France | $171.957B | 0.00 |
| Boston Scientific (BSX) | United States | $154.367B | 35.30 |
| Stryker (SYK) | United States | $140.480B | 27.89 |
| Medtronic (MDT) | Ireland | $122.894B | 17.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.851B | 0.00 |
| Agilent Technologies (A) | United States | $42.956B | 27.80 |
| ResMed (RMD) | United States | $36.903B | 25.54 |
| GE HealthCare Technologies (GEHC) | United States | $34.155B | 16.34 |
| Koninklijke Philips (PHG) | Netherlands | $28.291B | 18.48 |
| Terumo (TRUMY) | Japan | $22.712B | 25.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.842B | 11.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.285B | 0.00 |
| Baxter (BAX) | United States | $9.613B | 7.76 |
| Sunny Optical Technology (SNPTF) | China | $9.339B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.828B | 31.74 |
| Demant (WILYY) | Denmark | $7.496B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.614B | 11.01 |
| ICU Medical (ICUI) | United States | $3.435B | 21.81 |
| Haemonetics (HAE) | United States | $3.423B | 15.23 |
| Envista Holdings (NVST) | United States | $3.308B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.910B | 13.27 |
| LeMaitre Vascular (LMAT) | United States | $2.041B | 41.08 |
| Perrigo (PRGO) | Ireland | $1.949B | 4.88 |
| Curaleaf Holdings (CURLF) | Canada | $1.869B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.837B | 18.35 |
| AtriCure (ATRC) | United States | $1.644B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.535B | 9.86 |
| Green Thumb Industries (GTBIF) | United States | $1.452B | 63.64 |
| Neogen (NEOG) | United States | $1.406B | 26.96 |
| Tilray Brands (TLRY) | Canada | $1.381B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.261B | 18.27 |
| BioLife Solutions (BLFS) | United States | $1.248B | 370.29 |
| InMode (INMD) | Israel | $0.923B | 10.44 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.830B | 0.00 |
| Valneva SE (VALN) | France | $0.790B | 0.00 |
| Surmodics (SRDX) | United States | $0.591B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.513B | 17.64 |
| CeriBell (CBLL) | United States | $0.477B | 0.00 |
| Evolus (EOLS) | United States | $0.473B | 0.00 |
| SNDL (SNDL) | Canada | $0.470B | 0.00 |
| Omeros (OMER) | United States | $0.469B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.441B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.413B | 0.00 |
| Cerus (CERS) | United States | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.300B | 52.60 |
| Sanuwave Health (SNWV) | United States | $0.286B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.285B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.268B | 0.00 |
| High Tide (HITI) | Canada | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 151.00 |
| Viemed Healthcare (VMD) | United States | $0.249B | 19.85 |
| Quanterix (QTRX) | United States | $0.244B | 0.00 |
| Owens & Minor (OMI) | United States | $0.227B | 2.28 |
| TriSalus Life Sciences (TLSI) | United States | $0.220B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 15.88 |
| FitLife Brands (FTLF) | United States | $0.178B | 21.93 |
| OraSure Technologies (OSUR) | United States | $0.177B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Biote (BTMD) | United States | $0.131B | 5.28 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| Sharps Technology (STSS) | United States | $0.104B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 0.00 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.38 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.26 |
| Nephros (NEPH) | United States | $0.048B | 35.08 |
| Jin Medical (ZJYL) | China | $0.042B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Zynex (ZYXI) | United States | $0.033B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Bonk (BNKK) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.28 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |